These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6704976)

  • 21. Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial.
    Kirkwood JM; Ensminger W; Rosowsky A; Papathanasopoulos N; Frei E
    Cancer Res; 1980 Jan; 40(1):107-13. PubMed ID: 7349890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats.
    Erdlenbruch B; Jendrossek V; Kugler W; Eibl H; Lakomek M
    Cancer Chemother Pharmacol; 2002 Oct; 50(4):299-304. PubMed ID: 12357304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraarterial administration of melphalan for treatment of intracranial human glioma xenografts in athymic rats.
    Kurpad SN; Friedman HS; Archer GE; McLendon RE; Petros WM; Fuchs HE; Guaspari A; Bigner DD
    Cancer Res; 1995 Sep; 55(17):3803-9. PubMed ID: 7641197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent.
    Kyle AH; Huxham LA; Baker JH; Burston HE; Minchinton AI
    Cancer Res; 2003 Sep; 63(18):5707-11. PubMed ID: 14522888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics of vinblastine by continuous intravenous infusion.
    Lu K; Yap HY; Loo TL
    Cancer Res; 1983 Mar; 43(3):1405-8. PubMed ID: 6825110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J; Modiano M; Clairmont C; Lambert P; Savaraj N; Doyle T; Sznol M
    Clin Cancer Res; 2003 Sep; 9(11):4092-100. PubMed ID: 14519631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical phase I-II and pharmacokinetic study of high-dose thymidine given by continuous intravenous infusion.
    Chiuten DF; Wiernik PH; Zaharko DS; Edwards L
    Cancer Res; 1980 Mar; 40(3):818-22. PubMed ID: 7471098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of bromodeoxyuridine sensitivity of cultured cells from melanoma metastases.
    Poot M; Hiller KH; Heimpel S; Schuster A; Köhler J; Hoehn H
    Cytometry; 1995 Sep; 21(1):62-7. PubMed ID: 8529473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous intravenous infusions of bromodeoxyuridine as a clinical radiosensitizer.
    Kinsella TJ; Mitchell JB; Russo A; Aiken M; Morstyn G; Hsu SM; Rowland J; Glatstein E
    J Clin Oncol; 1984 Oct; 2(10):1144-50. PubMed ID: 6092551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraarterial therapy of human glioma xenografts in athymic rats using 4-hydroperoxycyclophosphamide.
    Schuster JM; Friedman HS; Archer GE; Fuchs HE; McLendon RE; Colvin OM; Bigner DD
    Cancer Res; 1993 May; 53(10 Suppl):2338-43. PubMed ID: 8485721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].
    Nakagawa H; Miyawaki Y; Tokiyoshi K; Tsuruzono K; Yamada M; Kanayama T; Hayakawa T
    No Shinkei Geka; 1994 Jan; 22(1):35-42. PubMed ID: 8295700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosensitization with carotid intra-arterial bromodeoxyuridine +/- 5-fluorouracil biomodulation for malignant gliomas.
    Greenberg HS; Chandler WF; Ensminger WD; Sandler H; Junck L; Page MA; Crane D; McKeever P; Tankanow R; Bromberg J
    Neurology; 1994 Sep; 44(9):1715-20. PubMed ID: 7936303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue-specific pharmacodynamics of 5-bromo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
    Stetson PL; Maybaum J; Wagner JG; Averill DR; Wollner IS; Knol JA; Johnson NJ; Yang ZM; Preiskorn D; Smith P
    Cancer Res; 1988 Dec; 48(23):6900-5. PubMed ID: 3180098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I and pharmacological study of acivicin by 24-hour continuous infusion.
    Weiss GR; McGovren JP; Schade D; Kufe DW
    Cancer Res; 1982 Sep; 42(9):3892-5. PubMed ID: 7105049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans.
    Schilsky RL; Kelley JA; Ihde DC; Howser DM; Cordes RS; Young RC
    Cancer Res; 1982 Apr; 42(4):1582-6. PubMed ID: 7060028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.
    Kellie SJ; Koopmans P; Earl J; Nath C; Roebuck D; Uges DR; De Graaf SS
    Cancer; 2004 Jun; 100(12):2637-43. PubMed ID: 15197807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.
    Greene RF; Collins JM; Jenkins JF; Speyer JL; Myers CE
    Cancer Res; 1983 Jul; 43(7):3417-21. PubMed ID: 6850648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States.
    Comis RL; Issell BF; Pittman K; Ginsberg SJ; Rudolph A; Aust JC; DiFino SM; Tinsley RW; Poiesz BJ; Crooke ST
    Cancer Res; 1982 Jul; 42(7):2944-8. PubMed ID: 7083181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-Bromo-2'-deoxyuridine incorporation into DNA in hepatic VX2 tumor-bearing rabbits.
    Knol JA; Stetson PL; Wagner JG; Johnson NJ; Yang ZM; Prieskorn D; Terrio P; Knutsen CA; Ensminger WD
    J Surg Res; 1989 Aug; 47(2):112-6. PubMed ID: 2755115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.